Resmed (RMD) cash: $1.4B
Resmed held $1.4B in cash and cash equivalents on Dec 31, 2025, up 171.5% from $522M a year earlier.
From Resmed's filings with the SEC · Read the filing · RMD stock page
Resmed cash by year
#396 of 4,171 US companies by cash · See the full ranking
| Year ended | Cash | Change |
|---|---|---|
| Dec 31, 2025 | $1.4B | +171% |
| Dec 31, 2024 | $522M | +148% |
| Dec 31, 2023 | $210M | -17% |
| Dec 31, 2022 | $253M | +30% |
| Dec 31, 2021 | $194M | – |
Cash of similar companies
Companies in the same industry as Resmed, by SEC industry code, with the closest cash. Each name opens the same page for that company.
| Company | Cash, latest year | Year ended |
|---|---|---|
| Baxter International | $2B | Dec 31, 2025 |
| Boston Scientific | $2B | Dec 31, 2025 |
| Medline | $1.9B | Dec 31, 2025 |
| Resmed | $1.4B | Dec 31, 2025 |
| Dexcom | $918M | Dec 31, 2025 |
| Solventum | $878M | Dec 31, 2025 |
| West Pharmaceutical Services | $791M | Dec 31, 2025 |
Questions and answers
What is Resmed's cash?
Resmed held $1.4B in cash and cash equivalents on Dec 31, 2025, up 171.5% from $522M a year earlier.
Numbers as reported in Resmed's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology